Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I R Judson

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Investigational New Drugs|November 11, 1999
A human capecitabine excretion balance and pharmacokinetic study after administration of a single oral dose of 14C-labelled drugI R Judson, P J Beale, J M Trigo, et al.
Magnetic Resonance in Medicine|September 1, 1995
Pharmacokinetics of the 13C labeled anticancer agent temozolomide detected in vivo by selective cross-polarization transferD Artemov, Z M Bhujwalla, R J Maxwell, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Combination of tamoxifen, aminoglutethimide, danazol and medroxyprogesterone acetate in advanced breast cancerJ R Hardy, T J Powles, I R Judson, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 12, 2010
Radiofrequency ablation is a feasible therapeutic option in the multi modality management of sarcomaR L Jones, J McCall, A Adam, et al.
Cancer Research|October 15, 1991
ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical studyA L Jackman, G A Taylor, W Gibson, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
A pharmacokinetic and pharmacodynamic study in vivo of human HT29 tumours using 19F and 31P magnetic resonance spectroscopyP M McSheehy, M T Seymour, A S Ojugo, et al.
NMR in Biomedicine|February 11, 2000
Measurement of the extracellular pH of solid tumours in mice by magnetic resonance spectroscopy: a comparison of exogenous (19)F and (31)P probesA S Ojugo, P M McSheehy, D J McIntyre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Phase I and pharmacokinetic study of an oral platinum complex given daily for 5 days in patients with cancerM J McKeage, F Raynaud, J Ward, et al.
Investigational New Drugs|December 18, 2009
Efficacy and safety of sorafenib in a subset of patients with advanced soft tissue sarcoma from a Phase II randomized discontinuation trialSimon Pacey, Mark J Ratain, Keith T Flaherty, et al.
Cancer Research|March 27, 1998
Carbogen breathing increases 5-fluorouracil uptake and cytotoxicity in hypoxic murine RIF-1 tumors: a magnetic resonance study in vivoP M McSheehy, S P Robinson, A S Ojugo, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Investigational New Drugs|November 11, 1999
A human capecitabine excretion balance and pharmacokinetic study after administration of a single oral dose of 14C-labelled drugI R Judson, P J Beale, J M Trigo, et al.
Magnetic Resonance in Medicine|September 1, 1995
Pharmacokinetics of the 13C labeled anticancer agent temozolomide detected in vivo by selective cross-polarization transferD Artemov, Z M Bhujwalla, R J Maxwell, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Combination of tamoxifen, aminoglutethimide, danazol and medroxyprogesterone acetate in advanced breast cancerJ R Hardy, T J Powles, I R Judson, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 12, 2010
Radiofrequency ablation is a feasible therapeutic option in the multi modality management of sarcomaR L Jones, J McCall, A Adam, et al.
Cancer Research|October 15, 1991
ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical studyA L Jackman, G A Taylor, W Gibson, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
A pharmacokinetic and pharmacodynamic study in vivo of human HT29 tumours using 19F and 31P magnetic resonance spectroscopyP M McSheehy, M T Seymour, A S Ojugo, et al.
NMR in Biomedicine|February 11, 2000
Measurement of the extracellular pH of solid tumours in mice by magnetic resonance spectroscopy: a comparison of exogenous (19)F and (31)P probesA S Ojugo, P M McSheehy, D J McIntyre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Phase I and pharmacokinetic study of an oral platinum complex given daily for 5 days in patients with cancerM J McKeage, F Raynaud, J Ward, et al.
Investigational New Drugs|December 18, 2009
Efficacy and safety of sorafenib in a subset of patients with advanced soft tissue sarcoma from a Phase II randomized discontinuation trialSimon Pacey, Mark J Ratain, Keith T Flaherty, et al.
Cancer Research|March 27, 1998
Carbogen breathing increases 5-fluorouracil uptake and cytotoxicity in hypoxic murine RIF-1 tumors: a magnetic resonance study in vivoP M McSheehy, S P Robinson, A S Ojugo, et al.
Pageof 7